Nifty 50 closed at 23,242.1, up 0.5% on the day, though it remains below its 200-day average and 11.7% off its 52-week high. The regime reads weak but recovering, now in its sixth consecutive day of that label, with the near-term read neutral-to-up. Breadth is narrow but improving — advancers led decliners 1,622 to 597, 147 new 52-week highs cleared against 96 new lows, and 15 golden crosses registered versus just one death cross. Just under 35% of NSE stocks sit above their 200-day average, so the recovery is real but still far from broad.
Sector rotation: Financials on top today, but the 3-month story belongs elsewhere
On the day, Financials led all sectors at +1.9%, followed by Real Estate at +1.7% and Industrials at +1.3%. That is a notable single-session move for Financials, though the sector is still one of the two worst performers over the past three months at -6.0%, alongside Energy at -6.5% — context worth keeping in mind when reading today's strength. Over three months the durable leaders have been Industrials at +15.8%, Health Care at +12.0%, and Utilities at +10.5%. Health Care also tops the one-month table at +2.1%, with Communication Services second at +1.1%. The rotation picture, then, is one where today's session brought a bounce in beaten-down Financials while the structural momentum remains concentrated in Industrials and Health Care.
Stage-2 expansion and where the screener is finding setups
The advancing cohort now accounts for 24.2% of the NSE universe and has been widening — up 3.6 over the past five days, 9.7 over 20 days, and 11.6 over 60 days. The five-day transition count reinforces that: 77 stocks moved from Stage 1 (basing) into Stage 2 (advancing) against just 7 moving the other way, a net of +70. The sectors where the Stage-2 cohort is expanding fastest are Energy, Materials, and Health Care — an interesting divergence given Energy's poor three-month price return, suggesting early-stage base formations are accumulating there rather than confirmed advances. Among today's fresh breakouts from the screen, Raghav Productivity Enhancers (Materials, setup score 9.4) and Panacea Biotec (Health Care, 8.8) carry the cleanest scores. On the sustained-setup list, Bliss GVS Pharma leads at 9.6, with Stylam Industries, Rain Industries, and Yasho Industries all scoring 9.4.
| Stock | Sector | Setup | % 1D |
|---|---|---|---|
| Raghav Productivity Enhancers Ltd | Materials | 9.4 | +7.4% |
| Panacea Biotec Ltd | Health Care | 8.8 | +9.9% |
| Rategain Travel Technologies Ltd | Information Technology | 7.6 | +0.6% |
| IND Swift Laboratories Ltd | Health Care | 7.3 | +3.3% |
| Skipper Ltd | Utilities | 7.0 | +2.0% |
| Bafna Pharmaceuticals Ltd | Health Care | 6.8 | -10.0% |
| Consolidated Finvest & Holdings Ltd | Financials | 6.3 | -2.2% |
| Sarla Performance Fibers Ltd | Consumer Discretionary | 5.9 | +0.5% |
| Sector | 1D | 1M | 3M | RS | Stage 2 |
|---|---|---|---|---|---|
| Financials | +1.9% | -5.7% | -6.0% | 58 | 22% |
| Real Estate | +1.7% | -6.7% | +3.2% | 39 | 9% |
| Industrials | +1.3% | -0.3% | +15.8% | 67 | 26% |
| Materials | +1.1% | -2.3% | +7.8% | 71 | 28% |
| Consumer Discretionary | +1.1% | -3.9% | +2.5% | 65 | 20% |
| Health Care | +1.0% | +2.1% | +12.0% | 72 | 33% |
| Consumer Staples | +0.8% | -5.3% | +1.1% | 54 | 32% |
| Energy | +0.4% | -8.6% | -6.5% | 60 | 46% |
| Information Technology | +0.1% | -3.2% | -1.3% | 39 | 18% |
| Utilities | +0.0% | -0.2% | +10.5% | 64 | 28% |
| Communication Services | -0.2% | +1.1% | +6.7% | 63 | 11% |
Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.
Nifty +0.4%: Industrials lead, breadth improving on a narrow tape
30% of stocks in Stage 2 and widening; 104 fresh Stage 1-to-2 transitions in five days
Nifty holds 23,989 as Real Estate and IT lead a narrow recovery
Breadth improving, Stage-2 cohort widening, and eight fresh breakouts on the screen today
Nifty +1%, Real Estate leads; Stage-2 cohort at 10-week widest
Breadth improving, 96 fresh Stage 1→2 transitions, Energy & Health Care expanding fastest